pcos treatment glp-1 medications are not approved by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label GLP-1, SGLT2 combination therapy provides

Allowing the pen to reach room temperature (typically 15-30 minutes before injection) significantly reduces the burning or stinging sensation

Cost-effectiveness insights are crucial as these drugs move toward broader clinical adoption.

For optimal stability and effectiveness, vials should be stored in a cool, dry place (see Section 2 for detailed storage information)

Quick Answer: Most patients see blood glucose improvements within 14 weeks of starting GLP-1 therapy, while noticeable weight loss typically becomes apparent after 46 weeks, with peak effects at 6072 weeks

Once weekly subcutaneous injection

Carnitine, with its antioxidant properties, helps mitigate oxidative damage by scavenging free radicals, protecting sperm mitochondria from oxidative stress, which is particularly important in the preservation of sperm motility and overall fertility